Dr. James Hendrix discusses his work studying the high rate of Alzheimer’s in the Down Syndrome community.

(25 minutes) Dr. James Hendrix is the Chief Scientific Officer at LuMind IDSC. In that role, Dr. Hendrix directs scientific initiatives for LuMind IDSC. A critical element of his role is to establish the nationwide Down Syndrome – Clinical Trial Network (DS-CTN) and to oversee the first clinical trial in the DS-CTN, the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study. The LIFE-DSR study is a natural history study focused on adults 25 years of age and older at high risk for Alzheimer’s disease. Dr. Hendrix is also focused on building potential collaborations with industry, academic and government scientists focused on Down syndrome research to maximize LuMind IDSC’s scientific impact. Prior to joining LuMind, Dr. Hendrix was Director of Global Science Initiatives, at the Alzheimer’s Association. 

For more about Dr. Hendrix and LuMind: https://www.lumindidsc.org/

Follow Different Brains on social media:

https://twitter.com/diffbrains

https://www.facebook.com/different.brains/

https://www.instagram.com/diffbrains/

Check out more episodes of Exploring Different Brains!

http://differentbrains.org/category/edb/